Stockreport

Positive Results Highlight Potential of Bempedoic Acid / Ezetimibe Combination for Hypercholesterolaemia with Type 2 Diabetes

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF  Bempedoic acid is an oral, once-daily ATP citrate lyase (ACL) inhibitor that reduces cholesterol synthesis in the liver Bempedoic acid / ezetimibe FDC achieved a robust [Read more]